Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP515730.RAclK3PKWe300qY9AnGnOd3mkLlX7FichsBEVY93uJX0U130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP515730.RAclK3PKWe300qY9AnGnOd3mkLlX7FichsBEVY93uJX0U130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP515730.RAclK3PKWe300qY9AnGnOd3mkLlX7FichsBEVY93uJX0U130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP515730.RAclK3PKWe300qY9AnGnOd3mkLlX7FichsBEVY93uJX0U130_provenance.
- NP515730.RAclK3PKWe300qY9AnGnOd3mkLlX7FichsBEVY93uJX0U130_assertion description "[Collectively, the data suggest that the human mAb 1F5, which has recently entered clinical development under the name CDX-1127, may provide direct antitumor activity against CD27-expressing lymphoma or leukemia, independent of its potential to enhance immunity through its agonistic properties.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP515730.RAclK3PKWe300qY9AnGnOd3mkLlX7FichsBEVY93uJX0U130_provenance.
- NP515730.RAclK3PKWe300qY9AnGnOd3mkLlX7FichsBEVY93uJX0U130_assertion evidence source_evidence_literature NP515730.RAclK3PKWe300qY9AnGnOd3mkLlX7FichsBEVY93uJX0U130_provenance.
- NP515730.RAclK3PKWe300qY9AnGnOd3mkLlX7FichsBEVY93uJX0U130_assertion SIO_000772 22589397 NP515730.RAclK3PKWe300qY9AnGnOd3mkLlX7FichsBEVY93uJX0U130_provenance.
- NP515730.RAclK3PKWe300qY9AnGnOd3mkLlX7FichsBEVY93uJX0U130_assertion wasDerivedFrom befree-20140225 NP515730.RAclK3PKWe300qY9AnGnOd3mkLlX7FichsBEVY93uJX0U130_provenance.
- NP515730.RAclK3PKWe300qY9AnGnOd3mkLlX7FichsBEVY93uJX0U130_assertion wasGeneratedBy ECO_0000203 NP515730.RAclK3PKWe300qY9AnGnOd3mkLlX7FichsBEVY93uJX0U130_provenance.
- befree-20140225 importedOn "2014-02-25" NP515730.RAclK3PKWe300qY9AnGnOd3mkLlX7FichsBEVY93uJX0U130_provenance.